In this issue of Radiology, Chow and Itagaki (1) report the findings of a bibliometric analysis of worldwide published interventional oncology (1O) research and express concern over the logistic (sigmoidal) growth pattern of published 10 research in the United States during the 12-year period from 1996 to 2008 relative to the linear or exponential growth in other nations. They also express concern over the un-derfunding of published 10 research in the United States relative to published research in radiology in general. Finally, they note that the apparent focus on liver cancer that is evident in the published 10 literature is misaligned with cancer research priorities. Most notable among these priorities is the number one cancer killer in the United States: bronchogenic carcinoma (2).
展开▼
